Skip to main content

Advertisement

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

Article metrics

  • 494 Accesses

The original article was published in Molecular Cancer 2017 16:48

Correction to: Mol Cancer (2017) 16:48

https://doi.org/10.1186/s12943-017-0615-x

After publication of the article [1], the author reported that this article contained some errors.

The photograph of sh-NC in Fig. 1c was misplaced. The correct version of the figure and the figure legend is presented below.

Fig. 1
figure1

Prognostic value of miR-30d expression in PCa patients and its functions on tumor growth and angiogenesis in vivo using LNCaP cell induced tumor xenografts. a Kaplan-Meier analyses of biochemical recurrence (BCR)-free survival and overall survival of PCa patients based on miR- 30d expression in Taylor and TCGA datasets. b LNCaP cells stably expressing miR-30d formed significantly larger tumor nodules and remarkably speeded up tumor xenografts growth compared with the controls. Conversely, PCa cells that permanently suppressed miR-30d expression led to the smaller tumor nodules and the slower tumor growth compared with the control. c Immunohistochemical analysis using pan-endothelial marker CD31 antibody. d VEGFA protein expression in different groups detected by Western blot analysis. Data were presented as Mean ± SD. *P < 0.05. **P < 0.01

Reference

  1. 1.

    Lin Z-y, Chen G, Zhang Y-q, He H-c, Liang Y-x, Ye J-h, Liang Y-k, Mo R-j, Jian-ming L, Zhuo Y-j, Zheng Y, Jiang F-n, Han Z-d, Shu-lin W, Zhong W-d, Chin-Lee W. MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer. 2017;16:48. https://doi.org/10.1186/s12943-017-0615-x.

Download references

Author information

Correspondence to Wei-de Zhong or Chin-Lee Wu.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lin, Z., Chen, G., Zhang, Y. et al. Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. Mol Cancer 18, 122 (2019) doi:10.1186/s12943-019-1051-x

Download citation